Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Amatine
2. Gutron
3. Midodrin
4. Midodrine
5. Midodrine Monohydrochloride
6. Midon
7. Monohydrochloride, Midodrine
8. Proamatine
9. St 1085
10. St-1085
11. St1085
1. 3092-17-9
2. 43218-56-0
3. Pro-amatine
4. Midodrine Hcl
5. Amatine
6. Hipertan
7. Gutron
8. Proamatine
9. Midodrine (hydrochloride)
10. St. Peter 224
11. (+-)-midodrine Hydrochloride
12. Metligine
13. Midodrine Monohydrochloride
14. A-4020 Linz
15. 2-amino-n-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide Monohydrochloride
16. (+/-)-midodrin
17. Nsc-758429
18. 59jv96ytxv
19. St-peter-224
20. St 1085 [as The Base]
21. St1085 Hydrochloride
22. (+/-)-midodrine Hydrochlorid
23. St-1085 Base
24. St-1085 Hydrochloride
25. Chebi:31847
26. (+-)-1-(2',5'-dimethoxyphenyl)-2-glycinamidoethanol Hydrochloride
27. 2-amino-n-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide;hydrochloride
28. (+-)-2-amino-n-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide Monohydrochloride
29. Metligene
30. Midamine
31. 2-amino-n-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]acetamide Hydrochloride
32. Dsstox_cid_27493
33. Dsstox_rid_82380
34. Dsstox_gsid_47493
35. 2-amino-n-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide Monohydrochloride
36. Rac-n-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]glycinamide Hydrochloride
37. A 4020 Linz
38. Acetamide, 2-amino-n-[2-(2,5-dimethoxyphenyl)-2-hydroxyethyl]-, Hydrochloride (1:1)
39. Smr000058833
40. Midodrine Hydrochloride [usan]
41. Einecs 256-148-3
42. Ts 701
43. Unii-59jv96ytxv
44. (+-)-midodrin Hydrochloride
45. 2-amino-n-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)acetamide Hydrochloride
46. Prestwick_625
47. Pro-amatine (tn)
48. Midodrine Hydrochloride [usan:usp:jan]
49. Midodrine, Hydrochloride
50. 1-(2',5'-dimethoxyphenyl)-2-glycinamidoethanol Hydrochloride
51. Ncgc00016620-01
52. 2-amino-n-(2-(2,5-dimethoxyphenyl)-2-hyyroxyethyl)acetamide Monohydrochloride
53. Acetamide, 2-amino-n-(beta-hydroxy-2,5-dimethoxyphenethyl)-, Hydrochloride
54. Cas-3092-17-9
55. Schembl41463
56. Mls001332567
57. Mls001332568
58. Mls002154233
59. Spectrum1503257
60. St 1085 Hydrochloride
61. Chembl1200461
62. Dtxsid1047493
63. 2-(2-chlorophenoxy)propionicacid
64. Hms1568h03
65. Hms1922o03
66. Pharmakon1600-01503257
67. Midodrine Hydrochloride (jan/usp)
68. Midodrine Hydrochloride [mi]
69. Tox21_110529
70. Tox21_302723
71. Ccg-39323
72. Hy-12749a
73. Mfcd00079455
74. Midodrine Hydrochloride [jan]
75. Nsc758429
76. S5734
77. Akos015895724
78. Tox21_110529_1
79. Cs-4689
80. Hs-0099
81. Midodrine Hydrochloride [mart.]
82. Midodrine Hydrochloride [vandf]
83. Nc00573
84. Nsc 758429
85. Acetamide, 2-amino-n-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, Monohydrochloride
86. Midodrine Hydrochloride [usp-rs]
87. Midodrine Hydrochloride [who-dd]
88. Ncgc00095311-01
89. Ncgc00178238-05
90. Ncgc00256810-01
91. Db-047933
92. Ft-0603627
93. Ft-0701302
94. Midodrine Hydrochloride [orange Book]
95. D01307
96. Midodrine Hydrochloride [usp Monograph]
97. 092m179
98. 218m560
99. A820652
100. Q-201404
101. Sr-05000001847-3
102. Q27114696
103. Midodrine Hydrochloride, Analytical Standard, For Drug Analysis
104. Midodrine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
105. (+/-)-2-amino-n-(.beta.-hydroxy-2,5-dimethoxyphenethyl)acetamide Monohydrochloride
106. 2-azanyl-n-[2-(2,5-dimethoxyphenyl)-2-oxidanyl-ethyl]ethanamide Hydrochloride
107. Acetamide, 2-amino-n-(2-(2,5-dimethoxyphenyl)-2-hydroxyethyl)-, Monohydrochloride, (+/-)-
Molecular Weight | 290.74 g/mol |
---|---|
Molecular Formula | C12H19ClN2O4 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 6 |
Exact Mass | 290.1033348 g/mol |
Monoisotopic Mass | 290.1033348 g/mol |
Topological Polar Surface Area | 93.8 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 263 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Midodrine hydrochloride |
Drug Label | Name: ProAmatine(midodrine hydrochloride) TabletsDosage Form: 2.5-mg, 5-mg and 10-mg tablets for oral administrationActive Ingredient: Midodrine hydrochloride, 2.5 mg, 5 mg and 10 mgInactive Ingredients: Colloidal Silicone Dioxide NF, Corn Starch N... |
Active Ingredient | Midodrine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg; 10mg |
Market Status | Prescription |
Company | Mylan Pharms; Impax Pharms; Apotex; Sandoz |
2 of 2 | |
---|---|
Drug Name | Midodrine hydrochloride |
Drug Label | Name: ProAmatine(midodrine hydrochloride) TabletsDosage Form: 2.5-mg, 5-mg and 10-mg tablets for oral administrationActive Ingredient: Midodrine hydrochloride, 2.5 mg, 5 mg and 10 mgInactive Ingredients: Colloidal Silicone Dioxide NF, Corn Starch N... |
Active Ingredient | Midodrine hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 2.5mg; 5mg; 10mg |
Market Status | Prescription |
Company | Mylan Pharms; Impax Pharms; Apotex; Sandoz |
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
Adrenergic alpha-1 Receptor Agonists
Compounds that bind to and activate ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Agonists.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16135
Submission : 2002-09-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16481
Submission : 2003-03-24
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18470
Submission : 2005-06-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-10-11
Pay. Date : 2018-10-04
DMF Number : 16017
Submission : 2002-06-21
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-10-29
Pay. Date : 2014-05-12
DMF Number : 16006
Submission : 2002-06-13
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-16
Pay. Date : 2013-09-25
DMF Number : 27464
Submission : 2013-09-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6315
Submission : 1986-03-10
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2014-07-01
Pay. Date : 2014-04-29
DMF Number : 28211
Submission : 2014-04-30
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30216
Submission : 2016-02-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15610
Submission : 2001-09-04
Status : Inactive
Type : II
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm : D-24 and D24/1 MIDC Kurkumbh Tal. Daund, Dist Pune 413 802, Maharashtra State
Date of Issue : 2018-12-03
Valid Till : 2021-07-09
Written Confirmation Number : WC-0424
Address of the Firm : Plot no. 61 Additional Ambernath Ambernath East Dist. Thane 421506 Maharashtra
Date of Issue : 2022-06-08
Valid Till : 2025-07-02
Written Confirmation Number : WC-0091
Address of the Firm : Sejavta, Ratlam, Madhya Pradesh
Date of Issue : 2019-07-15
Valid Till : 2022-07-14
Written Confirmation Number : WC-0084
Address of the Firm : Plot No 26, 29 & 31, Umraya Road, Village Dabhasa, Tal -Padra- 381 440, Vadodara...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Omgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.
About the Company : Omgene Life Sciences Private Limited is an R&D-driven biopharmaceutical company specializing in biopharmaceuticals, peptides, semi-synthetic, and synthetic actives. As a vertically...
About the Company : Established in 2016, a state-of-the-art R&D facility engaged in the development of Novel processes for Bulk Actives including Deuterated Actives, Advanced Intermediates and up the ...
About the Company : Apotex Pharmachem is a global fully integrated API R&D and manufacturing organization with its headquarters located in Brantford, Ontario, Canada and is a member of the Apotex grou...
About the Company : More than 35 years of dedication to quality, service and pursuit of excellence, CHEMO was founded by Hugo Sigman, M.D., and Silvia Gold, Biochemist, in Spain (Barcelona), in 1977, ...
About the Company : Emcure Pharmaceuticals Ltd. is a fast-growing fully integrated Indian pharmaceutical company with a global presence engaged in developing, manufacturing, and marketing a broad rang...
About the Company : Ipca Laboratories, headquartered in Mumbai, India, is a prominent pharmaceutical enterprise established in 1949. Over the years, Ipca has emerged as a leading player in India's pha...
About the Company : Alchemia is dedicated to the production of high-quality active ingredients and intermediates for the pharmaceutical industry. Our goal is to offer products manufactured to the hig...
About the Company : Mankind Pharma, came into existence in 1986. In 1991, the company was formed into a legal corporation. However, it actively started working as a fully integrated pharmaceutical com...
About the Company : Optimus is one of the fastest-growing pharmaceutical companies with 16 years of experience in providing the best quality of API, Intermediates & Finished formulations in Global mar...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Midodrine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Midodrine, including repackagers and relabelers. The FDA regulates Midodrine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Midodrine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Midodrine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Midodrine supplier is an individual or a company that provides Midodrine active pharmaceutical ingredient (API) or Midodrine finished formulations upon request. The Midodrine suppliers may include Midodrine API manufacturers, exporters, distributors and traders.
click here to find a list of Midodrine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Midodrine DMF (Drug Master File) is a document detailing the whole manufacturing process of Midodrine active pharmaceutical ingredient (API) in detail. Different forms of Midodrine DMFs exist exist since differing nations have different regulations, such as Midodrine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Midodrine DMF submitted to regulatory agencies in the US is known as a USDMF. Midodrine USDMF includes data on Midodrine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Midodrine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Midodrine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Midodrine Drug Master File in Japan (Midodrine JDMF) empowers Midodrine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Midodrine JDMF during the approval evaluation for pharmaceutical products. At the time of Midodrine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Midodrine suppliers with JDMF on PharmaCompass.
A Midodrine written confirmation (Midodrine WC) is an official document issued by a regulatory agency to a Midodrine manufacturer, verifying that the manufacturing facility of a Midodrine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Midodrine APIs or Midodrine finished pharmaceutical products to another nation, regulatory agencies frequently require a Midodrine WC (written confirmation) as part of the regulatory process.
click here to find a list of Midodrine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Midodrine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Midodrine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Midodrine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Midodrine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Midodrine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Midodrine suppliers with NDC on PharmaCompass.
Midodrine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Midodrine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Midodrine GMP manufacturer or Midodrine GMP API supplier for your needs.
A Midodrine CoA (Certificate of Analysis) is a formal document that attests to Midodrine's compliance with Midodrine specifications and serves as a tool for batch-level quality control.
Midodrine CoA mostly includes findings from lab analyses of a specific batch. For each Midodrine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Midodrine may be tested according to a variety of international standards, such as European Pharmacopoeia (Midodrine EP), Midodrine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Midodrine USP).
LOOKING FOR A SUPPLIER?